1h Free Analyst Time
The accelerating demand for safe, reliable blood supplies has propelled automated blood bank analyzers into a position of strategic importance. These advanced systems streamline donor screening, blood typing, and compatibility testing, replacing labor-intensive manual processes with high-throughput precision. As healthcare providers face mounting pressure to reduce errors, optimize workflows, and manage costs, automated analyzers deliver consistent results and faster turnaround times. Moreover, integration with laboratory information systems ensures seamless data handling and regulatory compliance.Speak directly to the analyst to clarify any post sales queries you may have.
Amid rising complexity in transfusion medicine and heightened quality standards, industry stakeholders-from blood banks to research institutes-are rethinking their infrastructure investments. Innovative technologies such as immunoassays, nucleic acid amplification, and microarrays are redefining analytical capabilities, while automation levels span fully robotic solutions to semi-automated platforms tailored to diverse operational scales. This introduction outlines the market’s core drivers, emerging opportunities, and foundational context for deeper exploration in subsequent sections.
Transformative Shifts in the Automated Blood Banking Landscape
Recent years have witnessed transformative shifts reshaping the landscape of blood bank automation. First, the convergence of advanced immunology assays-incorporating both direct and indirect ELISA formats alongside liquid- and solid-phase radioimmunoassays-has expanded screening accuracy and throughput. Simultaneously, nucleic acid amplification techniques such as loop-mediated isothermal amplification (LAMP) and transcription-mediated amplification (TMA) have elevated pathogen detection sensitivity, reducing window-period risks.Meanwhile, integration of electronic pipetting systems and auto sampler analyzers with robust firmware controls has enhanced reproducibility and minimized manual intervention. Software and interactive solutions now feature intuitive dashboards, AI-driven anomaly detection, and remote monitoring capabilities, creating end-to-end transparency. These shifts underscore a broader move toward modular, interoperable platforms that adapt to evolving testing demands, regulatory requirements, and budgetary constraints.
Cumulative Impact of United States Tariffs 2025 on Automated Analyzers
The imposition of updated U.S. tariffs in 2025 has introduced a notable headwind for instrument manufacturers and reagent suppliers alike. Increased duties on imported analyzers and consumables have elevated production costs, prompting vendors to reassess supply chain strategies. Some companies have responded by diversifying manufacturing footprints, relocating assembly lines closer to end markets to mitigate tariff exposure. Others have accelerated localization of key components to preserve margin structures.Healthcare providers, in turn, face higher acquisition and maintenance expenses. Budget-conscious blood banks and laboratories are exploring financing models and extended service contracts to spread upfront investments. Although the tariff adjustments have imposed short-term pressures, they have also stimulated innovation in cost containment. Collaborative procurement initiatives and bulk reagent agreements have emerged as viable tactics, while domestic OEMs leverage proximity advantages to gain incremental market share. Overall, the tariff landscape has catalyzed a recalibration of commercial and operational priorities across the ecosystem.
Key Insights Derived from Market Segmentation
A closer examination of market segmentation reveals nuanced drivers and strategic imperatives. Based on technology type, platforms span from traditional biochemical and centrifugation approaches to immunology offerings that include both enzyme-linked immunoassays-direct and indirect-and radioimmunoassays in liquid- and solid-phase formats, as well as advanced microarray, nucleic acid amplification (LAMP and TMA), and polymerase chain reaction methods. In terms of product type, the landscape comprises instruments such as auto sampler analyzers and electronic pipettes, consumables including cloning and transfection reagents, and comprehensive software solutions that enable data visualization and connectivity.When viewed through the lens of application, the market addresses critical functions from blood typing to disease screening-encompassing chronic disease panels and pre-transfusion testing-and extends into DNA and RNA analysis. End users range from government and non-profit blood banks to centralized and decentralized clinical laboratories, private and public hospitals, and both academic and commercial research institutes. Automation levels diversify offerings into fully automated and semi-automated configurations, while firmware components integrate analyzers with sensor modules to ensure precise control and real-time diagnostics. This segmentation matrix guides targeted investment and innovation strategies, highlighting priority areas for differentiated value propositions.
Regional Dynamics Shaping Automated Blood Bank Analyzer Adoption
Regional dynamics play a pivotal role in shaping market trajectories. In the Americas, robust healthcare infrastructure, extensive blood donation networks, and a strong regulatory framework foster widespread adoption of high-throughput automated systems. Competitive reimbursement policies further accelerate deployment. Conversely, the Europe, Middle East & Africa region presents a mosaic of maturity levels: Western Europe leads with standardized blood safety protocols and digital lab initiatives, while emerging markets in the Middle East and Africa are prioritizing capacity building and cold chain enhancements.In the Asia-Pacific, rapid urbanization, expanding clinical laboratory networks, and government programs targeting transfusion-transmissible infections have led to surging demand. Countries such as China, India, and Japan are investing in both domestic manufacturing capabilities and international collaborations. This regional spread underscores the importance of customizing product portfolios, service models, and training programs to address diverse operational realities and regulatory environments.
Leading Companies Driving Innovation and Growth
Innovation and competition within the automated blood bank analyzer market are driven by a cadre of established and emerging players. Abbott Laboratories continues to enhance immunohematology platforms, while Beckman Coulter, Inc. focuses on integrating high-capacity centrifugation modules with seamless data management. Becton, Dickinson and Company has capitalized on automated sampling workflows, and Bio-Rad Laboratories, Inc. underscores its strength in multiplex immunoassays.Meanwhile, Danaher Corporation, via Radiometer, advances point-of-care solutions; Grifols S.A. expands reagent and kit portfolios; and HORIBA, Ltd. integrates novel sensor technology for rapid compatibility screening. Mindray Bio-Medical Electronics Co., Ltd. is scaling up fully automated installations across Asia, whereas Ortho Clinical Diagnostics refines its direct and indirect ELISA offerings. Randox Laboratories Ltd. emphasizes niche molecular diagnostics, and Roche Diagnostics continues to invest in PCR-based analyzers. Siemens Healthineers AG leads in end-to-end automation, Sysmex Corporation drives microarray and nucleic acid platforms, and Thermo Fisher Scientific leverages its reagent supply chain for comprehensive system bundles. Collectively, these companies shape innovation roadmaps, strategic alliances, and M&A activity, defining competitive benchmarks.
Actionable Recommendations for Industry Leaders in Blood Bank Automation
To capitalize on evolving opportunities, industry leaders should adopt a multipronged approach. First, prioritize modular automation architectures that enable incremental upgrades, balancing capital efficiency with scalability. Second, invest in localized manufacturing partnerships and regional service hubs to mitigate tariff impacts and ensure rapid after-sales support. Third, enhance software ecosystems by integrating AI-driven predictive maintenance, real-time analytics, and interoperability standards to deliver actionable insights and reduce downtime.Additionally, cultivate collaborative alliances with blood bank networks and research institutes to co-develop tailored assay panels addressing emerging infectious threats. Embrace flexible financing models-such as reagent rental and pay-per-test frameworks-to lower adoption barriers for smaller laboratories. Finally, strengthen workforce competency via targeted training programs and remote diagnostic tools, fostering trust in automation and ensuring compliance with evolving regulatory guidelines. This holistic strategy positions organizations to deliver differentiated value and sustain competitive advantage.
Conclusion: Navigating the Future of Blood Bank Automation
The automated blood bank analyzer sector stands at a critical inflection point. Advances in assay sensitivity, automation workflows, and digital integration promise to redefine transfusion safety and operational efficiency. However, market participants must navigate geopolitical headwinds, diverse regional requirements, and intensifying competition. Success hinges on the ability to innovate responsively, align commercial models with end-user budgets, and maintain robust supply chains.By synthesizing technological breakthroughs with strategic partnerships and customer-centric service offerings, organizations can unlock new growth avenues. The insights presented throughout this summary offer a foundation for informed decision-making, guiding investments in R&D, manufacturing footprints, and go-to-market tactics. As the landscape continues to evolve, proactive adaptation will be paramount to delivering on the promise of safer, more efficient blood banking.
Market Segmentation & Coverage
This research report categorizes the Automated Blood Bank Analyzers Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Biochemical
- Centrifugation
- Immunology
- Enzyme-Linked Immunoassays (ELISA)
- Direct ELISA
- Indirect ELISA
- Radioimmunoassay (RIA)
- Liquid-Phase RIA
- Solid-Phase RIA
- Enzyme-Linked Immunoassays (ELISA)
- Microarray
- Nucleic Acid Amplification
- Loop-Mediated Isothermal Amplification (LAMP)
- Transcription-Mediated Amplification (TMA)
- Polymerase Chain Reaction (PCR)
- Instruments
- Auto Sampler Analyzers
- Electronic Pipettes
- Reagent and Kits
- Cloning Reagents
- Transfection Reagents
- Software & Interactive Solutions
- Blood Typing
- Disease Screening
- Chronic Diseases
- Pre-Transfusion Testing
- DNA and RNA Analysis
- Blood Banks
- Government Blood Banks
- Non-Profit Blood Banks
- Clinical Laboratories
- Centralized Labs
- Decentralized Labs
- Hospitals
- Private Hospitals
- Public Hospitals
- Research Institutes
- Academic Research Centers
- Commercial Research Organizations
- Fully Automated
- Semi-Automated
- Firmware
- Analyzers
- Sensors
This research report categorizes the Automated Blood Bank Analyzers Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Automated Blood Bank Analyzers Market to delves into recent significant developments and analyze trends in each of the following companies:
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (via Radiometer)
- Grifols S.A.
- HORIBA, Ltd.
- Mindray Bio-Medical Electronics Co., Ltd.
- Ortho Clinical Diagnostics
- Randox Laboratories Ltd.
- Roche Diagnostics
- Siemens Healthineers AG
- Sysmex Corporation
- Thermo Fisher Scientific
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Blood Bank Analyzers Market, by Technology Type
8.1. Introduction
8.2. Biochemical
8.3. Centrifugation
8.4. Immunology
8.4.1. Enzyme-Linked Immunoassays (ELISA)
8.4.1.1. Direct ELISA
8.4.1.2. Indirect ELISA
8.4.2. Radioimmunoassay (RIA)
8.4.2.1. Liquid-Phase RIA
8.4.2.2. Solid-Phase RIA
8.5. Microarray
8.6. Nucleic Acid Amplification
8.6.1. Loop-Mediated Isothermal Amplification (LAMP)
8.6.2. Transcription-Mediated Amplification (TMA)
8.7. Polymerase Chain Reaction (PCR)
9. Automated Blood Bank Analyzers Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Auto Sampler Analyzers
9.2.2. Electronic Pipettes
9.3. Reagent and Kits
9.3.1. Cloning Reagents
9.3.2. Transfection Reagents
9.4. Software & Interactive Solutions
10. Automated Blood Bank Analyzers Market, by Application
10.1. Introduction
10.2. Blood Typing
10.3. Disease Screening
10.3.1. Chronic Diseases
10.3.2. Pre-Transfusion Testing
10.4. DNA and RNA Analysis
11. Automated Blood Bank Analyzers Market, by End-User
11.1. Introduction
11.2. Blood Banks
11.2.1. Government Blood Banks
11.2.2. Non-Profit Blood Banks
11.3. Clinical Laboratories
11.3.1. Centralized Labs
11.3.2. Decentralized Labs
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
11.5. Research Institutes
11.5.1. Academic Research Centers
11.5.2. Commercial Research Organizations
12. Automated Blood Bank Analyzers Market, by Automation Level
12.1. Introduction
12.2. Fully Automated
12.3. Semi-Automated
13. Automated Blood Bank Analyzers Market, by Component
13.1. Introduction
13.2. Firmware
13.2.1. Analyzers
13.2.2. Sensors
14. Americas Automated Blood Bank Analyzers Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Automated Blood Bank Analyzers Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Automated Blood Bank Analyzers Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Beckman Coulter, Inc.
17.3.3. Becton, Dickinson and Company (BD)
17.3.4. Bio-Rad Laboratories, Inc.
17.3.5. Danaher Corporation (via Radiometer)
17.3.6. Grifols S.A.
17.3.7. HORIBA, Ltd.
17.3.8. Mindray Bio-Medical Electronics Co., Ltd.
17.3.9. Ortho Clinical Diagnostics
17.3.10. Randox Laboratories Ltd.
17.3.11. Roche Diagnostics
17.3.12. Siemens Healthineers AG
17.3.13. Sysmex Corporation
17.3.14. Thermo Fisher Scientific
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AUTOMATED BLOOD BANK ANALYZERS MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED BLOOD BANK ANALYZERS MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED BLOOD BANK ANALYZERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AUTOMATED BLOOD BANK ANALYZERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. AUTOMATED BLOOD BANK ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED BLOOD BANK ANALYZERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BIOCHEMICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY LIQUID-PHASE RIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SOLID-PHASE RIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP), BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTO SAMPLER ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ELECTRONIC PIPETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLONING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TRANSFECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SOFTWARE & INTERACTIVE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD TYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRE-TRANSFUSION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DNA AND RNA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY GOVERNMENT BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NON-PROFIT BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CENTRALIZED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DECENTRALIZED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMMERCIAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 70. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 71. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 107. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 108. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 122. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 123. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 125. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 126. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 127. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 130. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 132. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 134. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 135. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 137. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 138. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. CANADA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 143. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 144. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 145. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 147. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 150. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 153. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 155. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 156. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 157. MEXICO AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 214. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 215. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 217. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 218. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 219. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 222. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 224. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 226. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 228. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 229. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 230. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 231. CHINA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 232. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 233. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 235. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 236. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 237. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 239. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 240. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 242. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 244. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 245. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 246. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 247. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 248. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 249. INDIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 250. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 253. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 254. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 268. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 269. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 271. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 272. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 273. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 275. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 276. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 278. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 280. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 281. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 282. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 283. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 284. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 285. JAPAN AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY FIRMWARE, 2018-2030 (USD MILLION)
TABLE 286. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAYS (ELISA), 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY REAGENT AND KITS, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY DISEASE SCREENING, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY BLOOD BANKS, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA AUTOMATED BLOOD BANK ANALYZERS MARKET SIZE, BY AUTOMATIO
Companies Mentioned
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (via Radiometer)
- Grifols S.A.
- HORIBA, Ltd.
- Mindray Bio-Medical Electronics Co., Ltd.
- Ortho Clinical Diagnostics
- Randox Laboratories Ltd.
- Roche Diagnostics
- Siemens Healthineers AG
- Sysmex Corporation
- Thermo Fisher Scientific
Methodology
LOADING...
